Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems

Area of Science:

• Hepatology
• Biomedical Engineering
• Regenerative Medicine

Background:

• Liver failure presents significant morbidity and mortality despite medical advancements.
• Bioartificial liver (BAL) support systems offer therapeutic potential but require further development.
• Key challenges include defining optimal functions, cell sources, and culture environments for BALs.

Purpose of the Study:

• To review critical issues in the development and application of bioartificial liver support systems.
• To examine the required functions, suitable cell types, and optimal culture conditions for BALs.
• To discuss strategies for enhancing the efficacy and safety of BAL technology.

Main Methods:

• Literature review of existing research on bioartificial liver support systems.
• Analysis of functional requirements for liver support.
• Evaluation of cell sources, including xenogenic hepatocytes and immortalized human hepatocyte lines.
• Assessment of culture condition improvements, such as media supplementation, scaffolds, and coculture.

Main Results:

• Essential BAL functions include ammonia detoxification and biotransformation of toxic compounds.
• Xenogenic hepatocytes and immortalized human hepatocyte lines are primary cell choices, each with associated risks (zoonoses, malignant infiltration).
• Improvements in culture conditions, including supplemented media, biodegradable scaffolds, and coculture, can prolong hepatocyte function.

Conclusions:

• Addressing the complexities of BAL design and function is crucial for clinical translation.
• Careful selection of cell types and optimization of culture environments are necessary to overcome current limitations.
• Further research into BAL technology holds promise for improving outcomes in patients with liver failure.